AMBP and ovarian carcinoma: In this respect, Matsuzaki et al. determined bikunin levels in plasma samples, by using ELISA, from 200 healthy controls, 200 patients with benign gynecologic diseases, and 327 patients with ovarian cancer, after treatment with chondroitin lyase ABC.